Histogenics
Rich Vaillant has a diverse work experience spanning several companies. Rich started their career at Boston Scientific in 1987, where they served as Operations Controller until 1999. In 2001, they joined ACMI as Corporate Operations Controller and Director of Financial Planning & Analysis, a position they held until 2006. Then, they became the CFO at Histogenics in 2006, where they currently work.
Rich Vaillant has a BS in Business Administration with a concentration in Accounting from Merrimack College. Rich also holds a Master of Science in Accounting (MSA) from Suffolk University - Sawyer Business School.
This person is not in any teams
Histogenics
Histogenics Corporation is a regenerative medicine company. The Company is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The Company's product candidate, NeoCart utilizes various aspects of regene...